𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibitory effects of 3′-methyl-3-hydroxy-chalcone on proliferation of human malignant tumor cells and on skin carcinogenesis

✍ Scribed by Yoshiko Satomi


Book ID
102864376
Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
956 KB
Volume
55
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


3'-methyl-3-hydroxy-chalcone (3'Me-34). a derivative of chalcone, inhibited the proliferation of various kinds of human malignant tumor cells, such as HGC-27 (gastric cancer), HeLa (cervical carcinoma), PANC-I (pancreatic cancer) and GOTO (neuroblastoma). Flow-cytometric analysis of HGC-27 cells revealed that 3'Me-3-C perturbed the cell cycle, i.e., it delayed passage through the S phase, and/or caused arrest in the Go/GI phase. 3'Me-3-C inhibited the binding of [6,7-3H]estradiol to type4 estrogen-binding sites dose-dependently, and altered the pattern of protein synthesis and phosphorylation, which may explain 3'Me-3-C-induced inhibition of cell proliferation. In addition, 3'Me-3-C also suppressed the promoting activity of 12-0-tetradecanoylphorbol-13-acetate on skin carcinogenesis in 7, I2-dimethylbenz[a]anthracene-initiated mice.


📜 SIMILAR VOLUMES


The inhibitory effects of 5-hydroxy-3,6,
✍ Peiju Qiu; Huashi Guan; Ping Dong; Shanshan Guo; Jinkai Zheng; Shiming Li; Yun C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

## Abstract **Scope:** Previously, we reported that 5‐hydroxy‐3,6,7,8,3′,4′‐hexamethoxyflavone (5HHMF), a polymethoxyflavone found in citrus peels, potently inhibited the growth of multiple human colon cancer cells. Herein, we further investigated the anti‐cancer mechanisms of 5HHMF in human colon

Inhibitory effects of a new bisphosphona
✍ Tadahiko Kubo; Shoji Shimose; Toshihiro Matsuo; Kumi Tanaka; Yuji Yasunaga; Akir 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 491 KB 👁 1 views

## Abstract Little is known about the biological effects of bisphosphonates on primary malignant bone tumors. The purpose of this study was to investigate the antitumor effects of newly developed minodronate (MIN) on a variety of human malignant bone tumors. We examined the effects of MIN and clini